Related content

Differentiation of 3-Hydroxy-3-methylglutaryl-coenzyme A Reductase Inhibitors by Their Relative Lipophilicity

By Joshi H.N.   Fakes M.G.   Serajuddin A.T.M.  

Pharmacy and Pharmacology Communications, Vol. 5, Iss. 4, 1999-04 ,pp. : 269-271

Pharmaceutical Press

Access to resources Recommend Favorite

Therapeutic Potential of 3-Hydroxy-3-Methylglutaryl Coenzyme A Reductase Inhibitors for the Treatment of Retinal and Eye Diseases

By  

CNS & Neurological Disorders - Drug Targets (Formerly Current Drug Targets - CNS & Neurological Disorders), Vol. 6, Iss. 4, 2007-08 ,pp. : 282-287

Bentham Science Publishers

Access to resources Recommend Favorite

3-Hydroxy-3-methylglutaryl coenzyme A reductase inhibitors increase the binding activity and nuclear level of Oct-1 in mononuclear cells

By Ortego M.   Hernandez A.G.   Bustos C.   Blanco-Colio L.M.   Hernandez-Presa M.A.   Tunon J.   Egido J.  

European Journal of Pharmacology, Vol. 448, Iss. 2, 2002-07 ,pp. : 113-121

Elsevier

Access to resources Recommend Favorite

Reduced cholesterol absorption in hamsters by crilvastatin, a new 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor

By Hajri T.   Chanussot F.   Ferezou J.   Riottot M.   Lafont H.   Laruelle C.   Lutton C.  

European Journal of Pharmacology, Vol. 320, Iss. 1, 1997-02 ,pp. : 65-71

Elsevier

Access to resources Recommend Favorite

Crilvastatin, a new 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitor, inhibits cholesterol absorption in genetically hypercholesterolemic rats

By Hajri T.   Ferezou J.   Laurelle C.   Lutton C.  

European Journal of Pharmacology, Vol. 286, Iss. 2, 1995-11 ,pp. : 131-136

Elsevier

Access to resources Recommend Favorite